Search

everythinglearnresearchcommunity

for

Search:↓

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Effective management of PCOS includes lifestyle changes, medication for menstrual regulation, fertility treatments, and cosmetic issue remedies.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

New treatments for male hypogonadism are effective and should be personalized.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Monitoring for adverse effects in clinical treatments is crucial.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Zebrafish helped find new ways to prevent drug-induced hair cell death and potential treatments for hearing loss.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Estrogen therapy can reduce skin aging but has cancer risks.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.